Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours (Q82326317)
scientific article published on 22 December 2009
Language:
(P31) (Q13442814)
(P50) (Q51034031)
(P304) 729-734
(P407) (Q1860)
(P433) 4
(P478) 46
(P577) Tuesday, December 22, 2009
(P921) (Q5452194)
(P1433) (Q332260)
(P1476) "Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours" (language: en)
(P2093) N Isambert
M Campone
E Bourbouloux
M Drouin
A Major
W Yin
R Capizzi
C Grieshaber
P Fumoleau
other details
description scientific article published on 22 December 2009

External Links